IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure

Sleep Apnea, Obstructive Clinical Trial

Official title:

A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01560975
• Other study ID #: TF-1108
• Status: Completed
• Phase: N/A
• First received: March 20, 2012
• Last updated: December 21, 2015
• Start date: March 2012
• Est. completion date: November 2012

Study information

• Verified date: December 2015
• Source: Sensimed AG
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Sleep apnea is characterized by repetitive episodes of decreased or interrupted airflow in the upper airways during sleep. Obstructive sleep apnea syndrome (OSAS) is the most common sleep-related breathing disorder and is characterized by repeated partial or complete upper airway collapse, gasping episodes, daytime sleepiness and fatigue. Once suspected, the diagnosis is made on the basis of anamnesis and a polysomnography (PSG) using the so-called respiratory disturbance index (RDI) to grade OSAS. Standard therapy consists of continuous positive airway pressure (CPAP) during sleep to prevent upper airway collapse. The association between OSAS and glaucoma has been extensively studied, although a few reports have been non-confirmatory. OSAS has been associated with reduced ocular blood flow, leading to hypoxia and hypercapnia, and as such, may represent a risk factor for glaucomatous optic neuropathy. OSAS has also been related to loss of nycthemeral rhythm of intraocular pressure (IOP). In addition, CPAP has been reported to increase IOP when used during nighttime.

The purpose of this study is to investigate how IOP varies in time, particularly during sleep in OSAS patients with or without glaucoma, and if the IOP variations are associated with the use of CPAP. IOP fluctuations will be monitored with SENSIMED Triggerfish®, a portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 10
• Est. completion date: November 2012
• Est. primary completion date: November 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Patients with a confirmed diagnosis of moderate to severe OSAS, determined by a RDI > 15 on PSG

• Patient has either POAG with controlled IOP or no glaucoma. Five of each will included in the study

• Patients under CPAP therapy

• Aged = 18 years, of either sex

• Not more than 4 diopters spherical equivalent on the study eye

• Not more than 2 diopters cylinder equivalent on the study eye

• Have given written informed consent, prior to any investigational procedures

Exclusion Criteria:

• Sleep disorders other than OSAS

• Use of sleep medication

• Patients with history of intraocular surgery (including laser therapy) within the last 3 months

• Corneal or conjunctival abnormality hindering contact lens adaptation

• Severe dry eye syndrome

• Patients with allergy to corneal anesthetic

• Patients with contraindications for silicone contact lens wear

• Patients not able to understand the character and individual consequences of the investigation

• Participation in other clinical research within the last 30 days

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Apnea
• Glaucoma
• Glaucoma, Open-Angle
• Primary Open-angle Glaucoma
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

Intervention

Device:
• SENSIMED Triggerfish®
Portable investigational device using a contact lens sensor that monitors the IOP fluctuation continuously over 24-hours

Locations

Country	Name	City	State
United States	The New York Eye and Ear Infirmary	New-York	New York

Sponsors (1)

Lead Sponsor	Collaborator
Sensimed AG

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Relationship Between IOP Fluctuation Pattern With or Without CPAP Therapy in Patients With Moderate to Severe OSAS With or Without POAG	24-hour IOP fluctuation pattern recorded using Triggerfish in patients with moderate to severe OSAS.; using CPAP in patients with or without POAG; not using CPAP in patients with or without POAG	24 hours	No
Secondary	Relationship Between the 24-hour IOP Fluctuation Patterns and Physiologic Parameters	Heart rate and ocular pulsation rate during sleep: using CPAP in patients with or without POAG; not using CPAP in patients with or without POAG	24-hours	No
Secondary	Effect After CPAP Removal on the IOP Pattern	IOP pattern immediately after CPAP removal upon waking in patients with or without POAG	30 min	No